financetom
Business
financetom
/
Business
/
--Super Micro Computer Guides For Q4 EPS of $7.62-$8.42 on Sales of $5.1-$5.5 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Super Micro Computer Guides For Q4 EPS of $7.62-$8.42 on Sales of $5.1-$5.5 Billion
Apr 30, 2024 1:22 PM

04:09 PM EDT, 04/30/2024 (MT Newswires) --

Price: 865.00, Change: +6.20, Percent Change: +0.72

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AMC Entertainment Refinances $2.45 Billion Debt to Extend Maturity
AMC Entertainment Refinances $2.45 Billion Debt to Extend Maturity
Jul 22, 2024
02:48 PM EDT, 07/22/2024 (MT Newswires) -- AMC Entertainment Holdings ( AMC ) said Monday it agreed to a series of refinancing transactions that will extend the maturity of about $2.45 billion debt from 2026 to 2029 and beyond. The company and its units issued $1.2 billion of new term loans for the purchase of $1.1 billion of existing term...
Premier Insider Sold Shares Worth $600,000, According to a Recent SEC Filing
Premier Insider Sold Shares Worth $600,000, According to a Recent SEC Filing
Jul 22, 2024
02:37 PM EDT, 07/22/2024 (MT Newswires) -- Craig S. McKasson, Chief Financial & Administrative Officer, on July 18, 2024, sold 30,000 shares in Premier (PINC) for $600,000. Following the Form 4 filing with the SEC, McKasson has control over a total of 288,110 shares of the company, with 288,110 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1577916/000095017024085198/xslF345X03/ownership.xml Price: 19.63, Change: +0.06, Percent...
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
Jul 22, 2024
HC Wainwright analyst initiated coverage on AnaptysBio Inc ( ANAB ) , a clinical-stage biotechnology company focused on delivering immunology therapeutics. AnaptysBio ( ANAB ) has a pipeline of checkpoint agonists, including rosnilimab, a PD-1 agonist in development for rheumatoid arthritis (RA) and ulcerative colitis (UC), and ANB032, a B and T cell lymphocyte attenuator (BTLA) agonist in development for...
Cassava Shares Rise After Incoming Chairman Gives Timeline for Alzheimer's Drug Study Read Out
Cassava Shares Rise After Incoming Chairman Gives Timeline for Alzheimer's Drug Study Read Out
Jul 22, 2024
02:39 PM EDT, 07/22/2024 (MT Newswires) -- Cassava Sciences ( SAVA ) shares were up nearly 24% in recent Monday trading after its recently appointed chairman told shareholders the biotech was expecting the first phase 3 trial read out of simufilam by December. In a letter to investors, Richard Barry, who was appointed executive chairman last week, said results from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved